SKELETON COAST URANIUM CORP (SKEL.CA) Fundamental Analysis & Valuation

TSX-V:SKEL • CA83058E1060

Current stock price

0.38 CAD
0 (0%)
Last:

This SKEL.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SKEL.CA Profitability Analysis

1.1 Basic Checks

  • In the past year SKEL has reported negative net income.
  • SKEL had a negative operating cash flow in the past year.
  • In the past 5 years SKEL always reported negative net income.
  • In the past 5 years SKEL always reported negative operating cash flow.
SKEL.CA Yearly Net Income VS EBIT VS OCF VS FCFSKEL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -500K -1M -1.5M

1.2 Ratios

  • SKEL has a worse Return On Assets (-385.29%) than 85.24% of its industry peers.
Industry RankSector Rank
ROA -385.29%
ROE N/A
ROIC N/A
ROA(3y)-264.18%
ROA(5y)-201.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SKEL.CA Yearly ROA, ROE, ROICSKEL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400 -400 600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for SKEL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SKEL.CA Yearly Profit, Operating, Gross MarginsSKEL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. SKEL.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, SKEL has about the same amount of shares outstanding.
  • SKEL has less shares outstanding than it did 5 years ago.
  • SKEL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SKEL.CA Yearly Shares OutstandingSKEL.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
SKEL.CA Yearly Total Debt VS Total AssetsSKEL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M

2.2 Solvency

  • Based on the Altman-Z score of -121.96, we must say that SKEL is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -121.96, SKEL is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -121.96
ROIC/WACCN/A
WACCN/A
SKEL.CA Yearly LT Debt VS Equity VS FCFSKEL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500K -500K 1M -1M

2.3 Liquidity

  • SKEL has a Current Ratio of 0.07. This is a bad value and indicates that SKEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SKEL has a worse Current ratio (0.07) than 87.14% of its industry peers.
  • A Quick Ratio of 0.07 indicates that SKEL may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.07, SKEL is doing worse than 86.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
SKEL.CA Yearly Current Assets VS Current LiabilitesSKEL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200K 400K 600K 800K 1M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. SKEL.CA Growth Analysis

3.1 Past

  • The earnings per share for SKEL have decreased strongly by -69.15% in the last year.
EPS 1Y (TTM)-69.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. SKEL.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SKEL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SKEL.CA Price Earnings VS Forward Price EarningsSKEL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SKEL.CA Per share dataSKEL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SKEL.CA Dividend Analysis

5.1 Amount

  • No dividends for SKEL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SKEL.CA Fundamentals: All Metrics, Ratios and Statistics

SKELETON COAST URANIUM CORP

TSX-V:SKEL (4/7/2026, 7:00:00 PM)

0.38

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-27
Earnings (Next)07-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.65%
Ins Owner ChangeN/A
Market Cap4.03M
Revenue(TTM)N/A
Net Income(TTM)-607.60K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -385.29%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-264.18%
ROA(5y)-201.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -121.96
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-69.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.5%
OCF growth 3YN/A
OCF growth 5YN/A

SKELETON COAST URANIUM CORP / SKEL.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SKELETON COAST URANIUM CORP?

ChartMill assigns a fundamental rating of 0 / 10 to SKEL.CA.


Can you provide the valuation status for SKELETON COAST URANIUM CORP?

ChartMill assigns a valuation rating of 0 / 10 to SKELETON COAST URANIUM CORP (SKEL.CA). This can be considered as Overvalued.


What is the profitability of SKEL stock?

SKELETON COAST URANIUM CORP (SKEL.CA) has a profitability rating of 0 / 10.